Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments.
Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.
For the first time in history, we now have the knowledge to unravel the genetic components of common and complex diseases. The increased understanding of molecular medicine is shifting clinical practice from treatment based on symptoms to treatment based on the underlying causes of disease. Physicians will be prescribing drugs that are designed more intelligently, work more effectively, and have fewer toxic side effects.
The mapping of the human genome was only the first step. Researchers are now working to translate variations in human genes to discover the underlying cause of disease progression and resistance to therapy and why some individuals encounter debilitating diseases and others live healthy lives. Although all the puzzle pieces of our genetic make-up have been identified, scientists and clinicians now have the formidable task of interpreting how they fit together in order to apply the genome map to patient care.
TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGens vision is of a world where an understanding of genomic variation can be rapidly translated to the diagnosis and treatment of disease in a manner tailored to individual patients.
TGen is dedicated to the next revolution in health care. With the patient at its helm, TGen is guided by three core principles: integrate, translate and accelerate.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi